Norway, April 17 -- Thor Medical, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, announced that its AlphaOne production facility at Heroya Industrial Park has reached mechanical completion. The plant is now fully constructed, on time and budget, and progressing as planned toward production start in the third quarter this year. Mechanical completion confirms that all major construction and installation activities have been finalized in accordance with project specifications. The facility has now entered the commissioning phase, which partly commenced already in March. During commissioning, systems and equipment are being tested, verified, and prepared for operational start-up. Commissioning acti...